31 July 2019 - The proposal was announced between two Democratic debates, seemingly timed to show that President Trump was also trying to tackle the highly populist issue of soaring drug prices.

The Trump administration said on Wednesday that it was taking steps to make it easier to import less expensive prescription drugs from other countries, particularly Canada. The move has long been supported by progressives but has encountered fierce opposition from the pharmaceutical industry.

The proposal would permit pilot programs developed by states, pharmacies or drug distributors that sought to safely import prescription medications from Canada. The FDA also planned to advise manufacturers on how they could import high-priced drugs like insulin that are sold more cheaply in other countries.

Read New York Times article